ASLAN Pharmaceuticals Limited ASLN
0.60 +0.60
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 12.00M | 0 | 0 | 0 | 3.00M | |
| 12.00M | 0 | 0 | 0 | 2.59M | |
| -43.74M | -47.88M | -33.85M | -16.48M | -45.58M | |
| -44.22M | -51.38M | -31.59M | -16.97M | -47.07M | |
| -22.00 | -30.00 | -20.00 | -16.00 | -58.00 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 21.25M | 56.90M | 90.17M | 14.32M | 22.20M | |
| 24.63M | 61.19M | 94.52M | 16.08M | 23.35M | |
| 37.91M | 52.82M | 37.21M | 26.23M | 23.95M | |
| 26.83M | 37.71M | 31.28M | 19.52M | 18.65M | |
| -13.29M | 8.37M | 57.30M | -10.45M | -1.68M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -43.32M | -35.96M | -34.00M | -15.05M | -25.51M | |
| 268.52K | 414.70K | -28.16K | 927 | 5.38K | |
| 10.72M | 4.72M | 109.87M | 7.17M | 19.09M | |
| -10.63K | -25.94K | -48.81K | -3.84K | 2.83K | |
| -35.65M | -33.27M | 75.84M | -7.88M | -6.71M |